Kelly Martin, Radius Health CEO

VC firms take os­teo­poro­sis drug­mak­er Ra­dius Health pri­vate for al­most $900M

Af­ter at­tacks from ac­tivist in­vestors and dis­ap­point­ing re­turns on share prices, Ra­dius Health has now agreed to new own­er­ship, a di­rec­tion re­sult­ing in leav­ing the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.